The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
Open accessAbstract
Vancomycin, metronidazole, and the bacteriocin lacticin 3147 are active against a wide range of bacterial species, including Clostridium difficile. We demonstrate that, in a human distal colon model, the addition of each of the three antimicrobials resulted in a significant decrease in numbers of C. difficile. However, their therapeutic use in the gastrointestinal tract may be compromised by their broad spectrum of activity, which would be expected to significantly impact on other members of the human gut microbiota. We used high-throughput pyrosequencing to compare the effect of each antimicrobial on the composition of the microbiota. All three treatments resulted in a decrease in the proportion of sequences assigned to the phyla Firmicutes and Bacteroidetes, with a corresponding increase in those assigned to members of the Proteobacteria. One possible means of avoiding such "collateral damage" would involve the application of a narrow-spectrum antimicrobial with specific anti-C. difficile activity. We tested this hypothesis using thuricin CD, a narrow-spectrum bacteriocin produced by Bacillus thuringiensis, which is active against C. difficile. The results demonstrated that this bacteriocin was equally effective at killing C. difficile in the distal colon model but had no significant impact on the composition of the microbiota. This offers the possibility of developing a targeted approach to eliminating C. difficile in the colon, without collateral damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thuricin-CD, a bacteriocin produced by Bacillus thuringiensis, has been shown to be as effective as vancomycin or metronidazole against C. difficile without impacting microbiota composition in a fecal-culture system that models human colon [124].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [124]
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
MEGAN analysis of metagenomic data
Huson, D. H., Auch, A. F., Qi, J., & Schuster, S. C. (2007) · Genome Research · doi:10.1101/gr.5969107 · Cited by 3,312
The gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791
Self-citationDethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., & Furet, J.-P. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-123 · Cited by 1,755
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Claesson, M. J., O'Sullivan, O., Wang, Q., Nikkilä, J., Marchesi, J. R., Smidt, H., de Vos, W. M., Ross, R. P., & O'Toole, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006669 · Cited by 880
Self-citationCorr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., & Gahan, C. G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700440104 · Cited by 853
Self-citationHALL, I. C. (1935) · American Journal of Diseases of Children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 772
Urich, T., Lanzén, A., Qi, J., Huson, D. H., Schleper, C., & Schuster, S. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002527 · Cited by 763
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 1×
“With respect to CDAD and antibiotic treatment, the strategies that have been used to address this issue include supplementation of the diet with probiotics (26, 32) and fecal transplantation (33).”
MethodReproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., & Young, V. B. (2009) · Infection and Immunity · doi:10.1128/iai.01520-08 · Cited by 550
Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913554107 · Cited by 530 · cited 3×
“difficile properties, which we have named thuricin CD (16).”
BackgroundSelf-citationSekirov, I., Tam, N. M., Jogova, M., Robertson, M. L., Li, Y., Lupp, C., & Finlay, B. B. (2008) · Infection and Immunity · doi:10.1128/iai.00319-08 · Cited by 490
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 2×
“An intact, fully developedGI tract microbiota also protects the host against invasion by pathogenic microorganisms through a highly complex set of events known as “colonization resistance” (1).”
BackgroundIdentification of Clostridium difficile as a cause of pseudomembranous colitis.
George, R. H., Symonds, J. M., Dimock, F., Brown, J. D., Arabi, Y., Shinagawa, N., Keighley, M. R., Alexander-Williams, J., & Burdon, D. W. (1978) · BMJ · doi:10.1136/bmj.1.6114.695 · Cited by 451
Hill, D. A., Hoffmann, C., Abt, M. C., Du, Y., Kobuley, D., Kirn, T. J., Bushman, F. D., & Artis, D. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.132 · Cited by 431
The Role of the Intestinal Tract as a Reservoir and Source for Transmission of Nosocomial Pathogens
Donskey, C. J. (2004) · Clinical Infectious Diseases · doi:10.1086/422002 · Cited by 424
Ryan, M. P., Rea, M. C., Hill, C., & Ross, R. P. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.2.612-619.1996 · Cited by 396
Self-citationTreatment of Clostridium difficile-associated disease: old therapies and new strategies
Aslam, S., Hamill, R. J., & Musher, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70215-2 · Cited by 366
The host–microbe interface within the gut
Shanahan, F. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0342 · Cited by 299
Self-citationUpdate of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
Kuijper, E. J., Barbut, F., Brazier, J. S., Kleinkauf, N., Eckmanns, T., Lambert, M. L., Drudy, D., Fitzpatrick, F., Wiuff, C., Brown, D. J., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.31.18942-en · Cited by 287
Croswell, A., Amir, E., Teggatz, P., Barman, M., & Salzman, N. H. (2009) · Infection and Immunity · doi:10.1128/iai.00006-09 · Cited by 277
Enterococcal infections & antimicrobial resistance.
Sood, S., Malhotra, M., Das, B. K., & Kapil, A. (2008) · PubMed · Cited by 275
Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin
Peláez, T., Alcalá, L., Alonso, R., Rodríguez-Créixems, M., García-Lechuz, J. M., & Bouza, E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1647-1650.2002 · Cited by 259
Yap, I. K. S., Li, J. V., Saric, J., Martin, F.-P., Davies, H., Wang, Y., Wilson, I. D., Nicholson, J. K., Utzinger, J., Marchesi, J. R., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr700864x · Cited by 230
Louie, T. J., Emery, J., Krulicki, W., Byrne, B., & Mah, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-07 · Cited by 190
Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains
Rea, M. C., Clayton, E., O'Connor, P. M., Shanahan, F., Kiely, B., Ross, R. P., & Hill, C. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47085-0 · Cited by 186
Self-citationMcFarland, L. V. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.09.002 · Cited by 181
Garner, C. D., Antonopoulos, D. A., Wagner, B., Duhamel, G. E., Keresztes, I., Ross, D. A., Young, V. B., & Altier, C. (2009) · Infection and Immunity · doi:10.1128/iai.01570-08 · Cited by 140
A statistical toolbox for metagenomics: assessing functional diversity in microbial communities
Schloss, P. D., & Handelsman, J. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-34 · Cited by 137
Freeman, J., Baines, S. D., Saxton, K., & Wilcox, M. H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm113 · Cited by 103
Citron, D. M., Merriam, C. V., Tyrrell, K. L., Warren, Y. A., Fernandez, H. T., & Goldstein, E. J. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2334-2338.2003 · Cited by 100
Fooks, L. J., & Gibson, G. R. (2003) · Anaerobe · doi:10.1016/s1075-9964(03)00043-x · Cited by 78
Inactivatin of metronidazole by Enterococcus faecalis
Nagy, E., & Földes, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.1.63 · Cited by 61
Baines, S. D., O'Connor, R., Saxton, K., Freeman, J., & Wilcox, M. H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn358 · Cited by 60
Rafii, F., Wynne, R. A., Heinze, T. M., & Paine, D. D. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00513-5 · Cited by 52
Altes und Neues zur antibiotikaassoziierten Diarrhö
Cramer, J. P., Burchard, G. D., & Lohse, A. W. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1040-0 · Cited by 11
Cited by
Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076
Self-citationBacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Self-citationMicrobiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
The intestinal epithelium: central coordinator of mucosal immunity
Allaire, J. M., Crowley, S. M., Law, H. T., Chang, S.-Y., Ko, H.-J., & Vallance, B. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.002 · Cited by 933
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Metadata
- Authors
- Rea, M. C., Dobson, A., O'Sullivan, O., Crispie, F., Fouhy, F., Cotter, P. D., Shanahan, F., Kiely, B., Hill, C., & Ross, R. P.
- Affiliations
- Teagasc - The Irish Agriculture and Food Development Authority (IE)
- Teagasc, Moorepark Food Research Centre, Fermoy, County Cork, Ireland;
- APC Microbiome Institute (IE)
- Alimentary Health (Ireland) (IE)
- University College Cork (IE)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-06-29
- Volume
- 108
- Issue
- supplement_1
- Pages
- 4639-4644
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3063588
- OpenAlex
- W2115717127
- Cited by
- 377
- References
- 39
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 23 · 2023: 28 · 2022: 29 · 2021: 21 · 2020: 26 · 2019: 31 · 2018: 21 · 2017: 32 · 2016: 30 · 2015: 25 · 2014: 27 · 2013: 24 · 2012: 15
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- College of Engineering, Michigan State University
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Clostridium difficile, vancomycin, metronidazole, lacticin 3147, bacteriocins, gut microbiota, microbial diversity, Firmicutes, Bacteroidetes, Proteobacteria, Clostridium difficile infection
- MeSH terms
- Anti-Bacterial Agents, Bacteriocins, Base Sequence, Colon, Feces, Humans, Metronidazole, Models, Biological, Molecular Sequence Data, Vancomycin, Clostridioides difficile, Sequence Analysis, DNA, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.